News

The multicenter, clinical study in patients with early cervical cancer will seek to assess and provide data in support of the use of Lymphoseek in sentinel lymph node

The patent, No. 8,808,751, covers the company’s dry milling method for producing submicron-sized particles that are 10 to 200 times smaller than conventional drug particles. "This patent further

As such, the claims provide broad coverage for all opioids and other drugs prone to abuse that could leverage the DETERx technology platform. This is the sixth issued

In a poster on Monday, September 22, "Discovery and characterization of super-enhancer-associated dependencies in acute myeloid leukemia (AML)," Syros scientists demonstrated that by examining the entire genomes of

Highlights New campus will be located at intersection of Princeton Pike and Interstate 295 Construction is expected to begin this fall with occupancy planned by the end of

Olaptesed pegol is a PEGylated mirror-image (L-) oligonucleotide, which binds and neutralizes the chemokine CXCL12/SDF-1, preventing interaction with its receptors CXCR4 & CXCR7. The company develops a new

The drug has already been used in hospitals in Europe for some time and this will be the first introduction of the injection, licensed for use in the

As part of the deal, Atara will have the option to acquire a worldwide license to three clinical stage T-cell therapies. These therapies include T-cells activated against Epstein

The FDA fast track status helps in expediting the review and development of drugs which treat a serious or life-threatening condition and fill an unmet medical need. According